Intracardiac impedance response during acute AF internal cardioversion using novel rectilinear and capacitor-discharge waveforms

Autor: PR Walsh, Simon J Walsh, Ganesh Manoharan, Omar J. Escalona, A. S. Rababah

Publikováno v: Physiological Measurement. 37:1129-1145

Intracardiac impedance (ICI) is a major determinant of success during internal cardioversion of atrial fibrillation (AF). However, there have been few studies that have examined the dynamic behaviour of atrial impedance during internal cardioversion

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9ad2312560c561c58d0fa731a4b217
https://doi.org/10.1088/0967-3334/37/7/1129

Denoising RF defibrillator waveforms for intracardiac atrial substrate impedance characterisation using digital filtering techniques

Autor: A. S. Rababah, PR Walsh, Ganesh Manoharan, Omar J. Escalona, Vivek Kodoth

Publikováno v: IFMBE Proceedings ISBN: 9783319193861

Intra-cardiac impedance (ICI) is one of the major determinants of success during internal cardioversion of atrial fibrillation(AF) and is consequently of significant importance in the development of more effective cardioversion therapies. In this stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::88d7f16c3756b3827192c248d1d83265
https://doi.org/10.1007/978-3-319-19387-8_324

straight to the heart

Autor: Niall Waterman, Omar J. Escalona, PA Rodrigues, PR Walsh, Jose J. Velasquez

Publikováno v: Electronics Letters. 50:1178-1178

A battery-less, wirelessly-powered implantable defibrillator for atrial fibrillation is being developed by an international team of researchers in the UK, Venezuela and the US. With the ability to sense the electrical impedance of heart tissue, it co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::80bfc2c5df4da9ae6260c4bc4271c46b
https://doi.org/10.1049/el.2014.2798

Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.

Autor: Brocklebank V; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Walsh PR; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Smith-Jackson K; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Hallam TM; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Marchbank KJ; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Wilson V; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom., Bigirumurame T; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Dutt T; Department of Haematology, Royal Liverpool University Hospital, Liverpool, United Kingdom., Montgomery EK; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom., Malina M; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Great North Children's Hospital, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle, United Kingdom., Wong EKS; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom., Johnson S; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Great North Children's Hospital, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle, United Kingdom., Sheerin NS; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Kavanagh D; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; National Institute for Health and Care Research Newcastle Biomedical Research Centre, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom.

Publikováno v: Blood [Blood] 2023 Oct 19; Vol. 142 (16), pp. 1371-1386.

Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted Sequencing.

Autor: Tschernoster N; Cologne Center for Genomics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Institute of Human Genetics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. Electronic address: nikolai.tschernoster@uk-koeln.de., Erger F; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Institute of Human Genetics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Walsh PR; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., McNicholas B; School of Medicine, National University of Ireland Galway, Galway, Ireland., Fistrek M; Division of Nephrology, Arterial Hypertension Dialysis and Transplantation, Department of Internal Medicine, University Hospital Center Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia., Habbig S; Department of Pediatrics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Pediatrics, Cologne, Germany., Schumacher AL; FACS & Imaging Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany., Folz-Donahue K; FACS & Imaging Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany., Kukat C; FACS & Imaging Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany., Toliat MR; Cologne Center for Genomics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Becker C; Cologne Center for Genomics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Thiele H; Cologne Center for Genomics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Kavanagh D; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Nürnberg P; Cologne Center for Genomics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Beck BB; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Institute of Human Genetics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Altmüller J; Cologne Center for Genomics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Core Facility Genomics, Berlin, Germany; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. Electronic address: janine.altmueller@bih-charite.de.

Publikováno v: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2022 Jun; Vol. 24 (6), pp. 619-631. Date of Electronic Publication: 2022 Apr 08.